Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on October 28, 2026

Oct. 28, 2026

Nelipak Healthcare Packaging Awarded Silver Medal Sustainability Rating from EcoVadis

Indeterminate GlobeNewswire

Oct. 28, 2026

HealthCore Foundation Announces Nearly $250 Million Real Estate Transaction with Northbay Health to Support Outpatient Expansion in Northern California

Indeterminate GlobeNewswire

Oct. 28, 2026

Biosphere Secures $21 Million Department of War Contract for Biomanufacturing of Critical Chemicals

Indeterminate GlobeNewswire

Oct. 28, 2026

Manta Cares and Cancer Support Community SF Bay Area Partner to Bring AI-Powered Cancer Support to Northern California Patients and Families

Indeterminate GlobeNewswire

Oct. 28, 2026

Arcutis Appoints Rob Scott, MD to Board of Directors

Indeterminate GlobeNewswire

Oct. 28, 2026

OPKO Health to Report Third Quarter 2026 Financial Results on November 4, 2026

Indeterminate GlobeNewswire

Oct. 28, 2026

Actinogen pivotal Alzheimer’s disease trial database lock milestone - topline results on track for mid-November

Indeterminate GlobeNewswire

Oct. 28, 2026

Daré Bioscience Addresses New National Focus on Women’s Health in Virtual Investor “What This Means” Discussion

Indeterminate GlobeNewswire

Oct. 28, 2026

Avaí Bio and Austrianova Announce Publication in Frontiers in Aging Journal Highlighting Novel Cell Encapsulation-Based Approach to Sustained Klotho Delivery

Indeterminate GlobeNewswire

Oct. 28, 2026

SELLAS Life Sciences Reaches 80th Event in Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia

Indeterminate GlobeNewswire

Oct. 28, 2026

Palisade Bio Announces First Patient Dosed in Global Phase 2b ASCENTRA-UC Study Evaluating Once-Daily Oral PALI-2108 for the Treatment of Ulcerative Colitis

Indeterminate GlobeNewswire

Oct. 28, 2026

Spectral AI Schedules 2026 Third Quarter Financial Results and Conference Call

Indeterminate GlobeNewswire

Oct. 28, 2026

Chloe Kim Is Changing the Conversation Around ADHD in Women with Qelbree® for ‘Ms. Represented’ Campaign

Indeterminate GlobeNewswire

Oct. 28, 2026

Tarsus Pharmaceuticals Appoints Neera Clase as Chief Commercial Officer

Indeterminate GlobeNewswire

Oct. 28, 2026

RenovoRx to Participate at the Canaccord Genuity MedTech Diagnostics and Digital Health & Services Forum

Indeterminate GlobeNewswire

Oct. 28, 2026

Propanc Biopharma Advances Clinical Development Preparation for PRP Phase 1b First-In-Human Study in Up to 50 Advanced Cancer Patients

Indeterminate GlobeNewswire

Oct. 28, 2026

60 Degrees Pharmaceuticals Announces Partnership with The University of Southern Mississippi to Evaluate Castanospermine in Nonclinical Models of Alpha-Gal Syndrome

Indeterminate GlobeNewswire

Oct. 28, 2026

MaxCyte to Participate in Three Upcoming Investor Conferences

Indeterminate GlobeNewswire

Oct. 28, 2026

ProQR to Present Clinical and Preclinical Progress from AX-0810 and AX-0811 at Upcoming Conferences

Indeterminate GlobeNewswire

Oct. 28, 2026

BrainsWay to Report Third Quarter 2026 Financial Results on November 10, 2026

Indeterminate GlobeNewswire